Abstract: A pressure vessel for storing high-pressure gas has a structure including: a nozzle body which is coupled to a vessel body that defines an inner wall surface of the pressure vessel, and has an inner flow path through which gas flows inside and outside of the pressure vessel; and a locker which is fastened to a lower portion of the nozzle body, and the structure is configured to provide dual sealing including sealing at an inclined surface by fastening force of the locker generated by an inclined pressing end of the locker, and sealing in the locker by sealing members.

Abstract: Disclosed are a real number M-ary signal encoding method, where M is a real number having N time dimensions and L frequency dimensions, and an encoding apparatus using the encoding method. The real number M-ary encoding apparatus according to the present invention comprises a coding unit which codes every K (K is an integer) binary bit units of binary data DATA to generate a first input code and a second input code, a first signal generator which receives the first input code and generates N1 number of M1-ary signals, a second signal generator which receives the second input code and generates N2 number of M2-ary signals, and a first time division multiplexing module which temporally multiplexes the N1 number of M1-ary signals and the N2 number of M2-ary signals to generate a real number M-ary signal which utilizes a voltage ratio a (a=A2/A1) used for M1-ary and M2-ary signals to minimize a transmission error rate.

Abstract: A method for semiconductor devices on a substrate includes using gate structures which serve as active gate structures in a MOSFET region, as dummy gate structures in a JFET region of the device. The dummy gate electrodes are used as masks and determine the spacing between gate regions and source/drain regions, the width of the gate regions, and the spacing between adjacent gate regions according to some embodiments, thereby forming an accurately dimensioned transistor channel.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, lung, breast, mouse, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervix, ovary, and/or prostate cancer.

Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.

Abstract: An isolated antibody or an antigen-binding fragment thereof having a specific binding affinity to an epitope located within the domain 1 or domain 3 of human vascular endothelial growth factor receptor 2 (VEGFR2; SEQ ID NO: 74) is disclosed. The epitope within the domain 3 of the VEGFR2 is located between amino acid residues 250 and 270 of SEQ ID NO: 74. Use of the antibody or antigen-binding fragment thereof in the manufacture of a medicament for inhibiting tumor growth, tumor angiogenesis, and/or inducing cancer cell cytotoxicity in a subject in need thereof is also disclosed. Also disclosed is a method of detecting the presence of VEGFR2 in a tumor vascular endothelial cell or a cancer cell in a biological sample.

Abstract: The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to globo H, SSEA3, and SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and/or prostate cancer.

Abstract: An image acquiring method for acquiring an image using a measurement apparatus including an image acquiring means which acquires an image of a surface of a target to be measured in the unit of predetermined size pixels and a moving means capable of moving the target to be measured, the image acquiring method includes: acquiring an image of a first region from the surface of the target to be measured through the image acquiring means; acquiring an image of a second region, which is different from the first region, by moving the target to be measured, through the moving means; acquiring a differential image by subtracting, from either the image of the first region or the image of the second region, the other image; and overlapping the differential image multiple times.

Abstract: The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Abstract: A manufacturing method of a casing of an electronic device including the following steps is provided. First, a casing body is formed by an injection molding technology, and the casing body includes a button portion. Thereafter, a sensing assembly is electroplated on an inner surface of the casing body. The sensing assembly includes a first conductive line and two first contacts. The first conductive line forms a strain sensing pattern on the button portion, and the two first contacts connect to two ends of the first conductive line, respectively.

Abstract: An apparatus for manufacturing tow prepreg includes: a spreading roller which adjusts an incident angle of supplied fiber; and two or more coating rollers including a first roller and a second roller which rotate while having a gap between the first roller and the second roller, in which the fiber supplied from the spreading roller passes through the gap between the first roller and the second roller to be coated with resin. The incident angle of the fiber supplied for immersing the resin is adjusted to adjust tension applied to the fiber supplied to a coating roller, thereby adjusting the content of resin.

Abstract: A connector for a coaxial cable is configured to be mounted to a first threaded surface of a connecting head of an electronic device. The connector includes: a nut configured to be mounted to the first threaded surface; an inner sleeve coaxially arranged with the nut, wherein the inner sleeve has a second threaded surface configured to be mounted to the coaxial cable; and an outer sleeve coaxially arranged with the nut and sleeved over the inner sleeve, wherein the inner sleeve has a first rear-extension portion in an inner space in the outer sleeve, wherein an annular space is between the first rear-extension portion and the outer sleeve and has an axial length smaller than a distance between the inner sleeve and a rear end of the inner space.

Abstract: The present disclosure relates to anti-SSEA4 antibodies and bindings fragments thereof comprising specific complementarity determining regions capable of high affinity binding to SSEA4 molecules and SSEA4-associated expressing tumor cells, such as breast cancer, pancreatic cancer, and renal cancer cells. The anti-SSEA4 antibodies and binding fragments induce ADCC or CDC effects in the targeted tumor cells and inhibit and/or reduce the cancer/tumor proliferation. The present disclosure also provides anti-SSEA4 antibodies and binding fragments thereof as a pharmaceutical composition for treating cancer. In addition, the anti-SSEA4 antibodies and binding fragments are useful in the diagnosis of cancers.

Abstract: The invention provides an antibody specific to the ANGPTL4 protein capable of neutralizing proliferation and methods of making and using the same. The antibody of the invention is further directed to the C terminal region of the protein and may be capable of neutralizing cell proliferation and treating cancer. The antibody may be monoclonal and/or humanized antibody.

Abstract: A high-pressure includes a liner; a composite material surrounding an outer circumferential surface of the liner; a heat-transfer sheet formed on the outer circumferential surface of the liner; and a spacer disposed between the heat-transfer sheet and the composite material. The heat-transfer sheet and the spacer have a gap therebetween.

Abstract: A mask including patterned structures arranged sequentially along a predetermined direction and a peripheral area surrounding the patterned structures is provided. Each of the patterned structures includes an opening portion and a thinning portion surrounding the opening portion. The opening portion has through holes arranged in a matrix. An outline of the thinning portion has two side edges opposite to each other substantially parallel to the predetermined direction. The thinning portion is defined by an area demarked by the outline of the thinning portion and an outline of the opening portion. A thickness of the thinning portion is thinner than a thickness of the peripheral area.

Abstract: The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Abstract: An apparatus for fastening a pair of gas vessels includes: a plurality of first units formed of a composite material, spaced apart from each other in parallel with each other in a length direction of the gas vessel, and having the pair of gas vessels seated on both sides thereof; a second unit formed of a composite material and extending in the length direction of the gas vessels to integrally connect the plurality of first units; and a plurality of fastening units each of which extending along a circumference of the gas vessels to enclose the gas vessels seated on the first units and having both ends connected to the first units.

Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.